Table of Contents
In addition to the study “Pharmaceutical production market”, a detailed research of the sector was developed through analysis of the companies that registered this activity as core business and declared their data to NTRO (NACE codes analyzed: 2110; 2120 ). For a segmented approach of the domain companies were structured in 13 groups of size: 0; 0-100 K EUR; 100-500 K EUR; 500 K-1.000 K EUR; 1-5 Mn. EUR; 5-10 Mn. EUR; 10-20 Mn. EUR; 20-50 Mn. EUR; 50-100 Mn. EUR; 100-500 Mn. EUR; 500-1.000 Mn. EUR; OVER 1.000 Mn. EUR.
Number of companies analyzed: 164 (2013)
The report is structured as follows:
1. Graphic analysis and interpretation of the following categories of indicators:
a) Dynamic - annual variation of:
iii. Number of employees
iv. Number of companies
i. Net profit margin
ii. Turnover / employee
iii. Profit / employee
iv. Turnover / company
v. Profit / company
i. Inventories turnover
ii. Total assets turnover
iii. Receivables turnover
iv. Total debts / total assets
d) Debt ratios – total debts / total assets
2. Graphic analysis of the net profit formation of companies groups breakdown by turnover criterion.
Indicators calculated for 2008-2013 provide an extensive and thorough assessment of the development and influences registered in the market and are a barometer that addresses both companies on the specific field and firms in the consulting, auditing, market research areas.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...
PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...